Merrimack Pharmaceuticals, Inc.
MACK · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,989 | $19,439 | $14,203 | $14,038 |
| Short-Term Investments | $12,886 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $309 | $389 | $480 | $2,506 |
| Total Curr. Assets | $19,184 | $19,828 | $14,683 | $16,544 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $8 | $66 | $232 |
| Total NC Assets | $4 | $8 | $66 | $232 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19,188 | $19,836 | $14,749 | $16,776 |
| Liabilities | – | – | – | – |
| Payables | $74 | $188 | $120 | $123 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $367 | $401 | $442 | $647 |
| Total Curr. Liab. | $441 | $589 | $562 | $770 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $589 | $120 | $0 |
| Other Liabilities | $0 | -$589 | -$120 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $441 | $589 | $562 | $770 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,343 | $1,342 | $1,334 | $1,334 |
| Retained Earnings | -$548,817 | -$547,636 | -$546,092 | -$543,637 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $566,221 | $565,541 | $558,945 | $558,309 |
| Total Equity | $18,747 | $19,247 | $14,187 | $16,006 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $19,188 | $19,836 | $14,749 | $16,776 |
| Net Debt | -$5,989 | -$19,439 | -$14,203 | -$14,038 |